StreetInsider.com News Articles

Form 4 Korro Bio, Inc. For: Jun 10 Filed by: Behbahani Ali

Thu, 11 Jun 2026 18:10:00 -0400

si-local-file:///var/storage/secattach/20260611/26637045.html

Form 4 Korro Bio, Inc. For: Jun 10 Filed by: Behbahani Ali

Thu, 11 Jun 2026 18:10:00 -0400

si-local-file:///var/storage/secattach/20260611/26637045.html

Form 4 Korro Bio, Inc. For: Jun 10 Filed by: Meyers Rachel

Thu, 11 Jun 2026 18:07:00 -0400

si-local-file:///var/storage/secattach/20260611/26637028.html

Form 4 Korro Bio, Inc. For: Jun 10 Filed by: Meyers Rachel

Thu, 11 Jun 2026 18:07:00 -0400

si-local-file:///var/storage/secattach/20260611/26637028.html

Form 4 Korro Bio, Inc. For: Jun 10 Filed by: Bermingham Nessan

Thu, 11 Jun 2026 18:04:00 -0400

si-local-file:///var/storage/secattach/20260611/26637018.html

Form 4 Korro Bio, Inc. For: Jun 10 Filed by: Bermingham Nessan

Thu, 11 Jun 2026 18:04:00 -0400

si-local-file:///var/storage/secattach/20260611/26637018.html

Form 4 Korro Bio, Inc. For: Jun 10 Filed by: Knobil Katharine

Thu, 11 Jun 2026 18:01:00 -0400

si-local-file:///var/storage/secattach/20260611/26637010.html

Form 4 Korro Bio, Inc. For: Jun 10 Filed by: Knobil Katharine

Thu, 11 Jun 2026 18:01:00 -0400

si-local-file:///var/storage/secattach/20260611/26637010.html

Form 4 Korro Bio, Inc. For: Jun 10 Filed by: FORMELA JEAN FRANCOIS

Thu, 11 Jun 2026 17:58:00 -0400

si-local-file:///var/storage/secattach/20260611/26637000.html

Form 4 Korro Bio, Inc. For: Jun 10 Filed by: FORMELA JEAN FRANCOIS

Thu, 11 Jun 2026 17:58:00 -0400

si-local-file:///var/storage/secattach/20260611/26637000.html

Form 4 Korro Bio, Inc. For: Jun 10 Filed by: PEARSON TIMOTHY R

Thu, 11 Jun 2026 17:55:00 -0400

si-local-file:///var/storage/secattach/20260611/26636996.html

Form 4 Korro Bio, Inc. For: Jun 10 Filed by: PEARSON TIMOTHY R

Thu, 11 Jun 2026 17:55:00 -0400

si-local-file:///var/storage/secattach/20260611/26636996.html

Form 8-K Korro Bio, Inc. For: Jun 10

Thu, 11 Jun 2026 16:42:00 -0400

si-local-file:///var/storage/secattach/20260611/26636432.html

Form 8-K Korro Bio, Inc. For: Jun 10

Thu, 11 Jun 2026 16:42:00 -0400

si-local-file:///var/storage/secattach/20260611/26636432.html

Form 4 Korro Bio, Inc. For: May 29 Filed by: Aiyar Ram

Tue, 02 Jun 2026 07:00:00 -0400

si-local-file:///var/storage/secattach/20260602/26587182.html

Form 4 Korro Bio, Inc. For: May 29 Filed by: Aiyar Ram

Tue, 02 Jun 2026 07:00:00 -0400

si-local-file:///var/storage/secattach/20260602/26587182.html

Form 4 Korro Bio, Inc. For: May 28 Filed by: FORMELA JEAN FRANCOIS

Mon, 01 Jun 2026 17:35:00 -0400

si-local-file:///var/storage/secattach/20260601/26585257.html

Form 4 Korro Bio, Inc. For: May 28 Filed by: FORMELA JEAN FRANCOIS

Mon, 01 Jun 2026 17:35:00 -0400

si-local-file:///var/storage/secattach/20260601/26585257.html

Form 144 Korro Bio, Inc. Filed by: Aiyar Ram

Fri, 29 May 2026 15:09:00 -0400

si-local-file:///var/storage/secattach/20260529/26574200.html

Form 144 Korro Bio, Inc. Filed by: Aiyar Ram

Fri, 29 May 2026 15:09:00 -0400

si-local-file:///var/storage/secattach/20260529/26574200.html

Form 4 Korro Bio, Inc. For: May 26 Filed by: Aiyar Ram

Thu, 28 May 2026 17:07:00 -0400

si-local-file:///var/storage/secattach/20260528/26568791.html

Form 4 Korro Bio, Inc. For: May 26 Filed by: Aiyar Ram

Thu, 28 May 2026 17:07:00 -0400

si-local-file:///var/storage/secattach/20260528/26568791.html

Korro to Present at the 2026 Jefferies Global Healthcare Conference

Wed, 27 May 2026 07:00:00 -0400

CAMBRIDGE, Mass., May 27, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a biopharmaceutical company leveraging a novel Oligonucleotide Promoted Editing of RNA (OPERA^®) platform to develop a new class of genetic medicines for rare and highly prevalent diseases, today announced that Ram Aiyar, Ph.D., Chief Executive Officer and President, will present at the 2026 Jefferies Global Healthcare Conference being held in New York, NY on June 2^nd- 4^th, 2026. Dr. Aiyar’s presentation will take place on Thursday, June 4, 2026, at 4:20 pm ET.

About Korro

Korro is a biopharmaceutical company

Korro to Present at the 2026 Jefferies Global Healthcare Conference

Wed, 27 May 2026 07:00:00 -0400

About Korro

Korro is a biopharmaceutical company

Korro Bio selects KRRO-111 for alpha-1 antitrypsin deficiency treatment

Tue, 19 May 2026 07:00:50 -0400

Korro Bio Inc. (NASDAQ: KRRO) announced KRRO-111 as its development candidate for treating alpha-1 antitrypsin deficiency (AATD), a genetic disorder affecting liver and lung function.

The Cambridge, Massachusetts-based biopharmaceutical company said KRRO-111 is a subcutaneously delivered oligonucleotide designed to repair defective alpha-1 antitrypsin mRNA in liver cells. In preclinical studies using a mouse model of AATD, the compound demonstrated greater than 90% editing of SERPINA1 transcripts, resulting in approximately 90% repaired functional alpha-1 antitrypsin protein in plasma.

The treatment works by utilizing the liver's natural ADAR enzyme to correct a single nucleotide variant in AAT mRNA, restoring normal protein production. In repeat-dose